173 related articles for article (PubMed ID: 34745980)
1. Association of Virological Response to Antiviral Therapy With Survival in Intermediate-Stage Hepatitis B Virus-Related Hepatocellular Carcinoma After Chemoembolization.
Jin M; Chen Y; Hu S; Zhu M; Wang Y; Chen M; Peng Z
Front Oncol; 2021; 11():751777. PubMed ID: 34745980
[TBL] [Abstract][Full Text] [Related]
2. Effect of antiviral therapy in patients with low HBV DNA level on transarterial chemoembolization for hepatocellular carcinoma.
Kim MP; Yang JK; Jun BG; Kim YD; Cheon GJ; Jung HJ; Yoo JJ; Kim SG; Kim YS; Jeong SW; Jang JY; Kim HS; Lee SH
J Viral Hepat; 2021 Jul; 28(7):1011-1018. PubMed ID: 33759295
[TBL] [Abstract][Full Text] [Related]
3. Impact of antiviral therapy with nucleos(t)ide analog on survival of patients with HBV-related small hepatocellular carcinomas.
Wei Y; Yi Y; Tao C; Ye W; Zhao W
Cancer Manag Res; 2019; 11():8475-8486. PubMed ID: 31572002
[TBL] [Abstract][Full Text] [Related]
4. Effect of Nucleos(t)ide Analogs on Patients with Intermediate and Advanced Hepatitis B Virus-Related Hepatocellular Carcinoma.
Jian ZW; Wu XW; Chen ZX; Wang JC; Peng JY; Lao XM
Dig Dis Sci; 2019 Aug; 64(8):2187-2198. PubMed ID: 30815819
[TBL] [Abstract][Full Text] [Related]
5. Microvascular Invasion as a Predictor of Response to Treatment with Sorafenib and Transarterial Chemoembolization for Recurrent Intermediate-Stage Hepatocellular Carcinoma.
Peng Z; Chen S; Xiao H; Wang Y; Li J; Mei J; Chen Z; Zhou Q; Feng S; Chen M; Qian G; Peng S; Kuang M
Radiology; 2019 Jul; 292(1):237-247. PubMed ID: 31135299
[TBL] [Abstract][Full Text] [Related]
6. Impact of oral anti-hepatitis B therapy on the survival of patients with hepatocellular carcinoma initially treated with chemoembolization.
Zhou ZG; Zheng XR; Zhou Q; Shi M; Zhang YJ; Guo RP; Yuan YF; Chen MS; Lin XJ; Lao XM; Li SP
Chin J Cancer; 2015 May; 34(5):205-16. PubMed ID: 26058595
[TBL] [Abstract][Full Text] [Related]
7. Association of HBV DNA replication with antiviral treatment outcomes in the patients with early-stage HBV-related hepatocellular carcinoma undergoing curative resection.
Chen JL; Lin XJ; Zhou Q; Shi M; Li SP; Lao XM
Chin J Cancer; 2016 Mar; 35():28. PubMed ID: 26992891
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant Transarterial Chemoembolization for HBV-Related Hepatocellular Carcinoma After Resection: A Randomized Controlled Study.
Wang Z; Ren Z; Chen Y; Hu J; Yang G; Yu L; Yang X; Huang A; Zhang X; Zhou S; Sun H; Wang Y; Ge N; Xu X; Tang Z; Lau W; Fan J; Wang J; Zhou J
Clin Cancer Res; 2018 May; 24(9):2074-2081. PubMed ID: 29420221
[No Abstract] [Full Text] [Related]
9. Hepatitis B virus DNA levels and overall survival in hepatitis B-related hepatocellular carcinoma patients with low-level viremia.
Kim TS; Sinn DH; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
J Gastroenterol Hepatol; 2019 Nov; 34(11):2028-2035. PubMed ID: 31157456
[TBL] [Abstract][Full Text] [Related]
10. Validation of the six-and-twelve criteria among patients with hepatocellular carcinoma and performance score 1 receiving transarterial chemoembolization.
Wang ZX; Li J; Wang EX; Xia DD; Bai W; Wang QH; Yuan J; Li XM; Niu J; Yin ZX; Xia JL; Fan DM; Han GH
World J Gastroenterol; 2020 Apr; 26(15):1805-1819. PubMed ID: 32351295
[TBL] [Abstract][Full Text] [Related]
11. Transarterial Chemoembolization Combined With Hepatectomy for the Treatment of Intermediate-Stage Hepatocellular Carcinoma.
Zhou Q; Tuo F; Li R; Wang X; Wang J; Huang Z; Chen M; Huang J
Front Oncol; 2020; 10():578763. PubMed ID: 33251141
[TBL] [Abstract][Full Text] [Related]
12. The presence of microvascular invasion guides treatment strategy in recurrent HBV-related HCC.
Chen SL; Xiao H; Xie ZL; Shen JX; Chen ZB; Wang YQ; Li B; Peng ZW; Kuang M; Lai JM; Peng S
Eur Radiol; 2020 Jun; 30(6):3473-3485. PubMed ID: 32048035
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant trans-arterial chemoembolization after hepatectomy significantly improves the prognosis of low-risk patients with R0-stage hepatocellular carcinoma.
Xie H; Tian S; Cui L; Yan J; Bai Y; Li X; Wang M; Zhang F; Duan F
Cancer Manag Res; 2019; 11():4065-4073. PubMed ID: 31118814
[No Abstract] [Full Text] [Related]
14. Transarterial chemoembolization combined with recombinant human adenovirus type 5 H101 prolongs overall survival of patients with intermediate to advanced hepatocellular carcinoma: a prognostic nomogram study.
He CB; Lao XM; Lin XJ
Chin J Cancer; 2017 Jul; 36(1):59. PubMed ID: 28728568
[TBL] [Abstract][Full Text] [Related]
15. The safety and efficacy of transarterial chemoembolization combined with sorafenib and sorafenib mono-therapy in patients with BCLC stage B/C hepatocellular carcinoma.
Wu FX; Chen J; Bai T; Zhu SL; Yang TB; Qi LN; Zou L; Li ZH; Ye JZ; Li LQ
BMC Cancer; 2017 Sep; 17(1):645. PubMed ID: 28899349
[TBL] [Abstract][Full Text] [Related]
16. Comparison of overall survival on surgical resection versus transarterial chemoembolization with or without radiofrequency ablation in intermediate stage hepatocellular carcinoma: a propensity score matching analysis.
Lin CW; Chen YS; Lo GH; Hsu YC; Hsu CC; Wu TC; Yeh JH; Hsiao P; Hsieh PM; Lin HY; Shu CW; Hung CM
BMC Gastroenterol; 2020 Apr; 20(1):99. PubMed ID: 32272898
[TBL] [Abstract][Full Text] [Related]
17. Transarterial Chemoembolization (TACE) Combined with Sorafenib in Treatment of HBV Background Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Propensity Score Matching Study.
Yuan J; Yin X; Tang B; Ma H; Zhang L; Li L; Chen R; Xie X; Ren Z
Biomed Res Int; 2019; 2019():2141859. PubMed ID: 31467872
[TBL] [Abstract][Full Text] [Related]
18. Postoperative adjuvant arterial chemoembolization improves the survival of hepatitis B virus-related hepatocellular carcinoma: a retrospective control study.
Li F; Guo Z; Zhang Y; Wang H; Zhang X; Si T; Yu H; Qi L
Ir J Med Sci; 2015 Dec; 184(4):753-9. PubMed ID: 24972992
[TBL] [Abstract][Full Text] [Related]
19. Association of Addition of Ablative Therapy Following Transarterial Chemoembolization With Survival Rates in Patients With Hepatocellular Carcinoma.
English K; Brodin NP; Shankar V; Zhu S; Ohri N; Golowa YS; Cynamon J; Bellemare S; Kaubisch A; Kinkhabwala M; Kalnicki S; Garg MK; Guha C; Kabarriti R
JAMA Netw Open; 2020 Nov; 3(11):e2023942. PubMed ID: 33151315
[TBL] [Abstract][Full Text] [Related]
20. Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion.
Lee D; Lee HC; An J; Shim JH; Kim KM; Lim YS; Chung YH; Lee YS
Clin Mol Hepatol; 2018 Jun; 24(2):144-150. PubMed ID: 29665630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
